ALNYLAM PHARMACEUTICALS, INC. - COM (ALNY)

Q2 2023 13F Portfolio Holders as of 6/30/2023

Type / Class
Equity / COM
Number of holders
461
Total Shares
118M
Shares change
-1.08M
Total reported value, excl. options
$22.4B
Value change
-$212M
Put/Call ratio
1.28
Number of buys
209
Number of sells
-200
Price
$189.94
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.